(Q70966495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Phase I trial of Idarubicin (4-demethoxydaunorubicin) in adult acute leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

main subject

phase I clinical trial

1 reference

1 reference

M Hayat

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P Hurteloup

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

C Parmentier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

P Carde

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

J O Pico

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

M Schlumberger

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

G Chahine

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D Kamioner

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

15 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

375-379

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00171588

15 October 2019

exact match

0 references

cites work

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6595242

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6595242

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/6595242

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF00171588

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6595242%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference